The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy
Abstract
The relationship between immune activation and the development of early depressive symptoms were studied in 33 cancer patients undergoing cytokine therapy. Patients were treated either with subcutaneous IL-2 administered alone (n=13) or in association with IFN-alpha (n=5), or with IFN-alpha alone administered subcutaneously at low doses (n=5) or intravenously at high doses (n=10). The intensity of depressive symptoms was assessed during a clinical interview carried out before the start of cytokine therapy and five days later using the Montgomery and Asberg Depression Rating Scale (MADRS). On the same days, blood samples were collected for each patient to measure serum concentrations of cytokines (IL-6, IL-10, IL-1ra) and cytokine-receptors (sIL-2R, LIF-R). Results showed that patients treated with IL-2 or IL-2+IFN-alpha displayed concomitant mood symptoms and increased serum cytokine levels during treatment. In these patients, the intensity of depressive symptoms at endpoint was positively correlated with the increases measured in serum levels of IL-10 between baseline and endpoint. IL-10 is an anti-inflammatory cytokine that is produced in response to the production of pro-inflammatory cytokines, and thereby reflects an inflammatory response. These results support the hypothesis of close relationship between depressive symptoms and the activation of the cytokine network.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Humans who are treated for cancer and hepatitis C with high doses of pro-inflammatory cytokines also demonstrate these symptoms and are at high risk for developing MDD.[12,13]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [12]
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,089
Fever: Role of Pyrogens and Cryogens
Kluger, M. J. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.93 · Cited by 1,220
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Endotoxin produces a depressive-like episode in rats
Yirmiya, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01415-2 · Cited by 604
The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Denicoff, K. D., RUBINOW, D. R., PAPA, M. Z., SIMPSON, C., SEIPP, C. A., LOTZE, M. T., Chang, A. E., ROSENSTEIN, D., & Rosenberg, S. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-293 · Cited by 456
Indicators of immune activation in major depression
Sluzewska, A., RYBAKOWSKI, J. K., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M. H. J., & Wiktorowicz, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02783-7 · Cited by 384
Mood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine
Sluzewska, A., RYBAKOWSKI, J. K., Łaciak, M., Mackiewicz, A., Sobieska, M., & WIKTOROWICV, K. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32372.x · Cited by 306
Research works printed but not linked: 1
- Cavaillon, J.M., 1996. Les Cytokines. Masson, Paris, pp. 184–199.
Cited by
Sorted by citations
Items 101–200 of 201
Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue
Korenromp, I. H. E., Grutters, J. C., van den Bosch, J. M. M., Zanen, P., Kavelaars, A., & Heijnen, C. J. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.06.004 · Cited by 38
Heinzelmann, M. M., Lee, H., Rak, H., Livingston, W. S., Barr, T. L., Baxter, T., Scattergood-Keepper, L., Mysliwiec, V., & Gill, J. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.08.004 · Cited by 39
Depressão, antidepressivos e sistema imune: um novo olhar sobre um velho problema
Vismari, L., Alves, G. J., & Palermo‐Neto, J. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000500004 · Cited by 37
Role of IL-10 −1082, IFN-γ +874, and TNF-α −308 Genes Polymorphisms in Suicidal Behavior
Omrani, M. D., Boushehri, B., Bagheri, M., Salarilak, S., Alipour, A., Anoshae, M., & Massomi, R. (2009) · Archives of Suicide Research · doi:10.1080/13811110903266418 · Cited by 36
Browne, C. A., O’Brien, F. E., Connor, T., Dinan, T. G., & Cryan, J. F. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.031 · Cited by 35
Neuroinflammation in Alzheimer's Disease and Major Depression
Dobos, N., Korf, J., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.023 · Cited by 35
Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders
Kalinichenko, L. S., Kornhuber, J., & Müller, C. P. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100783 · Cited by 35
Wang, D., Lin, W., Pan, Y., KUANG, X.-Y., Qi, X., & Sun, H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.011 · Cited by 35
The use of wound healing assessment methods in psychological studies: A review and recommendations
Koschwanez, H. E., & Broadbent, E. (2010) · British Journal of Health Psychology · doi:10.1348/135910710x524633 · Cited by 35
Cytokines, Sickness Behavior, and Depression
Dantzer, R., Bluthé, R.-M., Castanon, N., Kelley, K. W., Konsman, J. P., Layé, S., Lestage, J., & Parnet, P. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50019-8 · Cited by 32
Ysseldyk, R., McQuaid, R. J., McInnis, O. A., Anisman, H., & Matheson, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195237 · Cited by 34
Painsipp, E., Herzog, H., & Holzer, P. D. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348171 · Cited by 31
Hépatite C, Interféron α et dépression : principales hypothèses physiopathologiques
Vignau, J., Karila, L., Costisella, O., & Canva, V. (2005) · L Encéphale · doi:10.1016/s0013-7006(05)82400-5 · Cited by 30
Karrenbauer, B. D., Müller, C. P., Ho, Y., Spanagel, R., Huston, J. P., Schwarting, R. K. W., & Pawlak, C. R. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.011 · Cited by 30
Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
Debnath, M., Doyle, K., Langan, C., McDonald, C., Leonard, B., & Cannon, D. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0019-0 · Cited by 28
Inflammatory insults and mental health consequences: does timing matter when it comes to depression?
Preez, A. D., Leveson, J., Zunszain, P. A., & Pariante, C. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000672 · Cited by 29
Sudom, K., Turrin, N. P., Hayley, S. P., & Anisman, H. (2004) · NeuroImmunoModulation · doi:10.1159/000079415 · Cited by 28
Stress, immunity, cytokines and depression
Anisman, H. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140601.x · Cited by 28
Rengasamy, M. L., Marsland, A. L., Spada, M. L., Hsiung, K. S., Kovats, T., & Price, R. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100177 · Cited by 29
Central metabolite changes and activation of microglia after peripheral interleukin-2 challenge
Schneider, P., Weber‐Fahr, W., Schweinfurth, N., Ho, Y., Sartorius, A., Spanagel, R., & Pawlak, C. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.011 · Cited by 25
Souza, L. C., Jessé, C. R., de Gomes, M. G., Viana, C. E., Mattos, E., Silva, N. C., & Boeira, S. P. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9691-8 · Cited by 27
Systemic inflammation and emotional responses during the COVID-19 pandemic
Hamilton, O. S., Cadar, D., & Steptoe, A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01753-5 · Cited by 24
Neurobehavioral consequences of small molecule-drug immunosuppression
Bösche, K., Weißenborn, K., Christians, U., Witzke, O., Engler, H., Schedlowski, M., & Hadamitzky, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.008 · Cited by 26
Sorri, A., Järventausta, K., Kampman, O., Lehtimäki, K. A., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., & Leinonen, E. V. J. (2018) · Brain and Behavior · doi:10.1002/brb3.933 · Cited by 23
Mello, B. S. F., Filho, A. J. M. C., Custódio, C. S., Rodrigues, P. D. A., Carletti, J. V., Vasconcelos, S. M. M., de Sousa, F. C. F., Sanders, L. L. O., & Macêdo, D. S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.083 · Cited by 22
Lathe, R., Singadia, S., Jordan, C. Y., & Riedel, G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227575 · Cited by 21
Krueger, C., Hawkins, K., Wong, S., Enns, M. W., Minuk, G. Y., & Rempel, J. D. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01408.x · Cited by 20
Remigio‐Baker, R. A., Allison, M., Schreiner, P. J., Szklo, M., Crum, R. M., Leoutsakos, J., Franco, M., Carnethon, M. R., Nettleton, J. A., Mujahid, M. S., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.05.004 · Cited by 19
Lee, B. O., Choi, W., Sung, N.-Y., Lee, S.-K., Lee, C. G., & Kang, J.-I. (2015) · Psycho-Oncology · doi:10.1002/pon.3865 · Cited by 25
Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases
Shie, F., Chen, Y., Chen, C., & Ho, I.-K. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9241-8 · Cited by 19
Lindemalm, C., Mozaffari, F., Choudhury, A., Björneklett, H. G., Lekander, M., Nilsson, B. R., Ojutkangas, M.-L., Österborg, A., Bergkvist, L., & Mellstedt, H. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0275-2 · Cited by 17
From conifers to cognition: Microbes, brain and behavior
Lathe, R., & Clair, D. S. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12680 · Cited by 16
Role of inflammation and cellular stress in brain injury and central nervous system diseases
Barone, F. C., & Kilgore, K. S. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.010 · Cited by 17
Does neuroimmune dysfunction mediate seasonal mood changes in winter depression?
Lam, R. W. M., Song, C., & Yatham, L. N. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.024 · Cited by 16
Measuring sickness behavior in the context of pancreatic cancer
Tobias, K. G., Rosenfeld, B. D., Pessin, H., & BREITBART, W. S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.01.002 · Cited by 16
Pro‐inflammatory cytokines and depression in a familial cancer registry
O'Connor, M., Irwin, M. R., Seldon, J. L., Kwan, L. C., & Ganz, P. A. (2006) · Psycho-Oncology · doi:10.1002/pon.1108 · Cited by 16
Henkel, A. W., Alali, H. N., Devassy, A. M., Alawadhi, M. M., & Redzic, Z. B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.012 · Cited by 16
Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments
Gupta, R. K., Kumar, R., & Bassett, M. L. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.3.355 · Cited by 14
Mechanisms of Behavioral and Neuroendocrine Effects of Interleukin‐1 in Mice
Neveu, P. J., & Liège, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05382.x · Cited by 14
Simon, A. E., Palmer, S. C., & Coyne, J. C. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544293.011 · Cited by 13
The hygiene hypothesis and affective and anxiety disorders
Rook, G. A. W., & Lowry, C. A. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_11 · Cited by 13
Die Häufigkeit psychischer Störungen bei körperlich Kranken
Arolt, V. (2004) · Steinkopff eBooks · doi:10.1007/978-3-662-12845-9_2 · Cited by 13
Simon, A. E., & Robb, K. A. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543579.131 · Cited by 18
Crick, D. C. P., Sanderson, E. C. M., Jones, H. J., Goulding, N., Borges, M. C., Clayton, G., Carter, A. R., Halligan, S. L., Lawlor, D. A., Khandaker, G. M., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.033 · Cited by 13
Lafitte, M., Tastet, S., Perez, P., Serisé, M.-A., Grandoulier, A. A., Aouizerate, B., Sibon, I., Capuron, L., & Couffinhal, T. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0015-3 · Cited by 11
Jun, T., Pae, C., Chae, J., Bahk, W., Kim, K., Pyo, C., & Han, H. J. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01076.x · Cited by 12
Hoprekstad, G. E., Skrede, S., Bartz-Johannessen, C. A., Joa, I., Reitan, S. K., Steen, V. M., Torsvik, A., Johnsen, E., Kroken, R. A., & Rettenbacher, M. A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100756 · Cited by 11
Interferon, tryptophan and depression
Fekkes, D., & Gool, A. R. V. (2003) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2003.00007.x · Cited by 11
Symptom clusters in palliative-stage cancer correlate with proinflammatory cytokine cluster
Nilsberth, C., Sackmann, V., Fransson, K., Jakobsson, M., Karlsson, M., & Milberg, A. (2023) · Annals of Palliative Medicine · doi:10.21037/apm-22-974 · Cited by 9
Alcohol-Dependence and the Microbiota-Gut-Brain Axis
Stärkel, P., Leclercq, S., Delzenne, N. M., & de Timary, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00017-7 · Cited by 9
The Production and Effects of Cytokines Depend on Brain Lateralization
Neveu, P. J. (2008) · Neuroimmune biology · doi:10.1016/s1567-7443(07)10026-0 · Cited by 10
Immunology and Developmental Psychopathology
Granger, D. A., Granger, G. A., & Granger, S. W. (2015) · Wiley eBooks · doi:10.1002/9780470939390.ch17 · Cited by 10
Moriarity, D. P. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100288 · Cited by 11
Berto, L. F., Suemoto, C. K., Moreno, A. B., da Fonseca, M. D. J. M., Nunes, M. A., Molina, M. D. C. B., Barreto, S. M., Diniz, M. D. F. H. S., Lotufo, P. A., Benseñor, I. M., et al. (2022) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2022.06.001 · Cited by 9
The role of inflammation and oxidative stress in depression and cardiovascular disease
Wood, S. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815015-3.00008-8 · Cited by 9
Vitamin D and depression in older adults: lessons learned from observational and clinical studies
Ceolin, G., Antunes, L. D. C., Moretti, M., Rieger, D. K., & Moreira, J. D. (2022) · Nutrition Research Reviews · doi:10.1017/s0954422422000026 · Cited by 10
Fialho, R., Pereira, M., Harrison, N. A., Rusted, J. M., & Whale, R. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.03.049 · Cited by 8
Pate, B. S., Smiley, C. E., Harrington, E. N., Bielicki, H., Davis, J. M., Reagan, L. P., Grillo, C. A., & Wood, S. K. (2024) · Autonomic Neuroscience · doi:10.1016/j.autneu.2024.103175 · Cited by 7
Pathways Driving Neuroprogression in Depression: The Role of Immune Activation
Oriolo, G., Grande, I., Martín‐Santos, R., Vieta, E., & Carvalho, A. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00010-6 · Cited by 6
Huang, M., Chen, M., Tu, P., Bai, Y., Su, T., Chan, Y. E., & Li, C. (2025) · CNS Spectrums · doi:10.1017/s1092852925000227 · Cited by 4
Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms
Bao, H., Chen, Y., Zhang, Y.-N., Lan, H., & Jin, K. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112656 · Cited by 4
Granger, D. A., Dreschel, N. A., & Shirtcliff, E. A. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546365.014 · Cited by 4
Role of neuropsychological assessment in cancer patients
Farace, E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545900.005 · Cited by 4
Niveles séricos de IL-6 y depresión en varones con cáncer de pulmón no microcítico avanzado.
Sánchez, J. M., Sánchez, P. T., Peiró, G., Sirera, R., de Lamo, M., Corbellas, C., Caballero, C. P., Blasco, A., & Camps, C. (2013) · Cited by 4
Porta, C., Pedrazzoli, P., & Paglino, C. (2011) · Immunotherapy · doi:10.2217/imt.11.19 · Cited by 3
Major Depression: An Immune-Inflammatory Disorder
Noto, C. D. S., Rizzo, L. B., Mansur, R. B., Brietzke, E. M., & Maes, M. H. J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_8 · Cited by 3
Depression in the Context of Cancer
Coups, E. J., Winell, J., & Holland, J. C. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch14 · Cited by 3
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
The Neuroimmune System in Psychiatric Disorders
Leyrer‐Jackson, J. M., DeKrey, G. K., & Thomas, M. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_39 · Cited by 2
Спирин, Н. А., & Kasatkin, D. S. (2008) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-008-9087-1 · Cited by 2
Elsayed, M., & Connor, C. J. (2018) · EMJ Dermatology · doi:10.33590/emjdermatol/10312460 · Cited by 3
The Neuroimmune System in Psychiatric Disorders
Murrin, L. C., & Thomas, M. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_34 · Cited by 2
The Impact of Inflammation on Brain Function and Behavior in Rodent Models of Affective Disorders
Farzana, F., Renoir, T., & Hannan, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00005-2 · Cited by 3
Treatment of Depression in Medical Illness
Raison, C. L., Purselle, D. C., Capuron, L., & Miller, A. H. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch9 · Cited by 2
Barnier, P. O. (2011) · Biblos-e Archivo (Universidad Autónoma de Madrid) · Cited by 2
Neuroinflammation in depression
Dobos, N. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Montelukast altered BDNF and CHRNA7 gene expression were associated with behavioral changes in rats.
Haider, K., Hummadi, Y. M. K. A. M., Guaim, R. M., & Ahmeid, M. S. (2025) · F1000Research · doi:10.12688/f1000research.169688.1 · Cited by 1
Porównanie wybranych parametrów układu immunologicznego u osób zdrowych i chorych na depresję
Pietruczuk, K., Jakuszkowiak‐Wojten, K., Landowski, J., & Witkowski, J. M. (2005) · Psychiatria · Cited by 1
Cytokines, social development and psychopathology
Granger, D. A., & Dreschel, N. A. (2005) · CRC Press eBooks · doi:10.1201/b14625-26 · Cited by 1
Paik, K. D. (2009) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Role of Interferon-Gamma and Leucine-Rich Repeat Kinase 2 in Stress-Related Pathology
Litteljohn, D. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11660
Giraud, V., Rascle, N., & Ravaud, A. (2005) · Psycho-Oncologie · doi:10.1007/s10332-005-0085-z
Verlaufsuntersuchung zellulärer Immunparameter bei schizophrenen Patienten
Möller, H. ‐. (2003)
Metabolic-Inflammation Aspects of Depression and Cardiovascular Disease
Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_14
Physical health and metabolic dysfunction in bipolar disorder
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107477278.021
Caraway, J. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Henry, C. J. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
The Mechanism of Checkpoint Inhibitors in Gynecologic Cancer
Karoutsos, P., Karoutsos, D., & Karoutsou, E. (2017) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000281
Wong, A. P. (2010) · TSpace (University of Toronto)
Cancer Immunotherapy: Friend or Foe of Mental Health?
Saghazadeh, A., & Rezaei, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64550-6_16
Iatrogenic, drug‑induced depressions
Hroudová, J. (2018) · Praktické lékárenství · doi:10.36290/lek.2018.058
Impact, Diagnosis, Phenomenology, and Biology
Coryell, W. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_156
Gesi, C., Carpita, B., Barberi, F. M., Cordone, A., & Dell’Osso, L. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_22-1
Medications associated with development of drug-induced depression
Ostroumova, O. D., Батюкина, C. В., Ebzeeva, E. Y., & Shatalova, N. A. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-11-36-45
Innate and Cell-Mediated Immunity
Dhabhar, F. S. (2007)
Thériault, R.-K. (2021) · The Atrium (University of Guelph) · doi:10.1503/jpn.200117
Cytokines and Stressors: Implications for Cancer Immunotherapy
Kusnecov, A. W., & Anisman, H. (2010) · Springer eBooks · doi:10.1007/978-90-481-3725-1_1
Gesi, C., Carpita, B., Barberi, F. M., Cordone, A., & Dell’Osso, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_22
Inflammatory Mediators in Major Depression and Bipolar Disorder (Russian Translation)
Sara, P., de Gennaro, M. E., & Francesco, B. (2024) · Juvenis scientia · doi:10.32415/jscientia_2024_10_5_28-55
Metadata
- Authors
- Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J.
- Affiliations
- Inserm (FR)
- Centre National de la Recherche Scientifique (FR)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Capuron, Lucile
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 26
- Issue
- 8
- Pages
- 797-808
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2047987784
- Cited by
- 201
- References
- 35
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 9 · 2019: 2 · 2018: 12 · 2017: 6 · 2016: 10 · 2015: 13 · 2014: 9 · 2013: 7 · 2012: 5
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- immune activation, depressive symptoms, cancer patients, interleukin-2, interferon-alpha, cytokine therapy, IL-10, serum cytokines, soluble interleukin-2 receptor, inflammation, mood disorders
- MeSH terms
- Affect, Aged, Carcinoma, Renal Cell, Depression, Female, Humans, Immunity, Interleukin-2, Kidney Neoplasms, Male, Middle Aged, Cytokines, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review